NYSE:PROF - Profound Medicl Stock Price, Forecast & News

Profound Medicl trades on the New York Stock Exchange (NYSE) under the ticker symbol "PROF."

Profound Medicl is scheduled to release their next quarterly earnings announcement on Tuesday, March 3rd 2020. View Earnings Estimates for Profound Medicl.

Profound Medicl issued an update on its FY 2019 Pre-Market earnings guidance on Friday, January, 10th. The company provided EPS guidance of for the period. The company issued revenue guidance of $5.4-5.4 million.

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Profound Medicl in the last year. There are currently 1 buy rating and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Strong Buy." View Analyst Ratings for Profound Medicl.

Headlines about PROF stock have been trending extremely negative on Friday, according to InfoTrie Sentiment Analysis. InfoTrie rates the sentiment of press coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Profound Medicl earned a news impact score of -4.2 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an impact on the stock's share price in the next few days. View News Stories for Profound Medicl.

Some companies that are related to Profound Medicl include Mitchell Services (MSV), SRC Energy (SRCI), Champion Iron (CIA), Champion Iron (CIA), Interfor (IFP), Hochschild Mining (HOC), Mount Gibson Iron (MGX), Maverix Metals (MMX), Kidman Resources (KDR), SilverCrest Metals (SILV), K92 Mining (KNT), Orocobre (ORE), Orocobre (ORL), Western Areas (WSA) and Maverix Metals (MMX).

Based on aggregate information from My MarketBeat watchlists, some companies that other Profound Medicl investors own include BCE (BCE), IBM (IBM), Gilead Sciences (GILD), Huntington Bancshares (HBAN), Methanex (MEOH), PacWest Bancorp (PACW), People's United Financial (PBCT), Pattern Energy Group (PEGI), Walgreens Boots Alliance (WBA) and AbbVie (ABBV).

Profound Medicl's stock is owned by many different of retail and institutional investors. Top institutional investors include FIL Ltd (6.40%), Gagnon Securities LLC (4.57%), Gagnon Advisors LLC (1.53%), Royce & Associates LP (1.28%), Renaissance Technologies LLC (0.08%) and Bank of Montreal Can (0.07%).

PROF stock was purchased by a variety of institutional investors in the last quarter, including FIL Ltd, Gagnon Securities LLC, Gagnon Advisors LLC, Royce & Associates LP, Renaissance Technologies LLC, Bank of Montreal Can and Bank of America Corp DE.

Shares of PROF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of PROF stock can currently be purchased for approximately $14.49.

Profound Medicl has a market capitalization of $220.90 million. Profound Medicl employs 64 workers across the globe.View Additional Information About Profound Medicl.

The official website for Profound Medicl is http://www.profoundmedical.com/.

The company can be reached via phone at 647-476-1350.